Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.

Cancer Med · 2018 · PMC6198219 · PMID 30240146

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

marginally significantP < 0.10so close (0.05 < p ≤ 0.1)

In multivariate analyses, we estimated the effect (HR) of each of the T‐cell mRNA markers adjusted for the effect of the clinicopathological parameters that were statistically significant or marginally significant in the univariate analysis ( P < 0.10).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.